LabConnect’s Post

#LabConnect #LivesDependOnIt #ClinicalTrials #SampleManagement #VaccineTrials When it comes to clinical trials, Patients Can't Wait. Vaccine studies can have a significant impact on supporting healthier communities around the world. However, they are often required to be executed swiftly and across multiple regions of the world. Through our global central lab services, #LabConnect successfully manages these challenges with expert clinical, operational, and analytical support to ensure the timely execution of your vaccine trial. #LabConnect – Lives Depend on it. ⭐ Get the Top Takeaways from our webinar “Clinical Sample Management: Expecting the Unexpected – How to Avoid Losing a Sample.“ ⭐https://lnkd.in/e2yp-v7d Learn more and explore how we can partner together to accelerate the development of new medicines.

"Pfizer Apologizes for Controversial Promotion of COVID Vaccine Without Sufficient Safety Data" https://lnkd.in/eMi6b6jZ Stay connected with us for the latest healthcare related updates and exclusive content. We appreciate your continued support and look forward to bringing you more in-depth coverage. Don't forget to follow us and turn on notifications so you never miss out! 📲 #TishhaNews #Update #BreakingNews #stayupdated #healthcare #hospitals

Great summary about what CANImmunize does in the Globe & Mail today!

Join Vaxxas Chief Technology Officer Angus Forster and the Vaxxas team at Australia's Vaccine Value Chain Conference in Sydney next week.   Angus will bring a biotech perspective to discussions in the Plenary 4 session on Tuesday, 21 May on Manufacturing: Supply, Demand and Sustainability.   Reach out to Angus and the team to learn more about how we are scaling up our #advancedmanufacturing capabilities at the Vaxxas Biomedical Facility in Brisbane to supply our vaccination technology for late-stage clinical programs and first commercial use.   Vaxxas' high-density microarray skin patch (HD-MAP) has the potential to transform vaccination and improve health outcomes globally.   Vaxxas is excited to be a bronze sponsor of this event bringing together for the first time experts and key decision-makers from government, industry, academia and the wider immunisation community to advance the local vaccine ecosystem in Australia.   #Vaxxas #VaccineValueChain #GlobalHealth

In this month's blog post, we are diving into vaccine myths. Vaccines have transformed public health, yet misconceptions persist, hindering progress. Together, we can debunk myths and champion science for healthier communities. Read the full blog at https://lnkd.in/e-8zacmB #vaccinetrials #clinicaltrials #VaccinesForLife #clinicalresearch #pharma

Check out our new blog on Debunking Myths about Vaccine Trials! While vaccine hesitancy stems from understandable concerns, the scientific evidence overwhelmingly shows that the benefits of vaccines greatly outweigh the very small risks. Claims of adverse effects have been thoroughly investigated and discredited through numerous quality studies. The clinical trial process for vaccines is strictly regulated, with intense scrutiny and oversight by independent government agencies. Safety is the top priority at every stage. Yes, it's a complex issue - but one key ethical consideration is the responsibility we have to society's welfare by preventing disease outbreaks through widespread vaccination. What are your thoughts ? Feel free to share your perspective. #vaccines #clinicalresearch #clinicaltrials #pharma

Scarcity of vaccines (and other drugs) in LMICs is not just about financial constraints. Many other factors, including limited domestic production facilities, poor infrastructure for storage and distribution, and a shortage of trained healthcare workers, all play a role in limiting patients' access to essential healthcare. At DRK Pharma we are staunch believers in the principle of global healthcare equity, and through our work we are helping LMICs to develop and manage their own healthcare needs. Hear more about our activities at the World Vaccine Congress in Washington next week. https://lnkd.in/d8Sc-EC6

Join Parexel experts Anne Kasmar and Leslie Johnston as they share their thoughts on the extremely fast pace required to test novel vaccines in large representative trials, lessons learned from the COVID pandemic, and best practices to enable efficiency in this difficult therapeutic area. Register below! #Vaccines #Webinar #ClinicalResearch #OperationalExcellence

Join Parexel experts Anne Kasmar and Leslie Johnston as they share their thoughts on the extremely fast pace required to test novel vaccines in large representative trials, lessons learned from the COVID pandemic, and best practices to enable efficiency in this difficult therapeutic area. Register below! #Vaccines #Webinar #ClinicalResearch #OperationalExcellence

Join Parexel experts Anne Kasmar and Leslie Johnston as they share their thoughts on the extremely fast pace required to test novel vaccines in large representative trials, lessons learned from the COVID pandemic, and best practices to enable efficiency in this difficult therapeutic area. Register below! #Vaccines #Webinar #ClinicalResearch #OperationalExcellence